Latest Articles

Data on ImmunoGen/Sanofi's SAR3419 - Analyst Blog

ImmunoGen, Inc. ( IMGN ) announced that results from the phase II STARLYTE study on SAR3419 (coltuximab ravtansine) were presented at the 50th annual meeting of American Society of Clinical Oncology (ASCO). ImmunoGen has an agreement with Sanofi (... Read >>


Indian Stocks: Time to Ride the Modi Wave?

Ahead of India's recent election, investors had anticipated a victory for Prime Minister Narendra Modi and his Bharatiya Janata Party (BJP). However, the outcome appears to have surpassed even the highest of expectations, with the BJP alone... Read >>

Dow Chemical Praises DOE's Proposal - Analyst Blog

The Dow Chemical Company ( DOW ) expressed its delight at the Department of Energy's (DOE) proposal which stated that it will modify its liquefied natural gas (LNG) export review process. DOE proposed modification of its procedure for reviewing... Read >>

Citigroup May Vend OneMain Financial - Analyst Blog

Citigroup Inc. 's ( C ) CEO Michael Corbat stated the possible sale of its consumer lending business OneMain Financial at an investor conference on Thursday. Mr Corbat revealed that the company has initiated the process and is weighing... Read >>

Northrop, Lockheed, GD Win DoD Deals - Analyst Blog

Defense majors picked up small ticket programs from the U.S. Department of Defense's (DoD) funding list on Friday, May 30, 2014. Amongst the gainers, in terms of number of contracts, Northrop Grumman Corp. ( NOC ) won three separate... Read >>

Bayer and Orion Ink Oncology Deal - Analyst Blog

Bayer ( BAYRY ) inked a global agreement with Orion Corporation for the development and commercialization of ODM 201. ODM 201 is being developed for the treatment of patients suffering from prostate cancer. Bayer and Orion intend to start... Read >>

3 Hot Staffing Companies for Employment Trends - Analyst Blog

Since the onset of the recession one of the fastest growing industry segments has been the Professional & Business Services segment (read temp jobs).  This segment has seen sustained traction for the past many quarters due to several economic... Read >>

Investor's Business Daily

Merck Presents Positive Trial Results For Cancer Drug

Merck ( MRK ) seeks to add potential new blockbuster drugs to its disease fighting arsenal as it takes on cancer and hepatitis C. On Monday, the drugmaker presented results from a phase one trial of... Read >>

Stock Worth Buying: Cohu - Analyst Blog

Zacks Investment Research upgraded Cohu, Inc. ( COHU ) to a Zacks Rank #1 (Strong Buy) on May 30, 2014. Going by the Zacks model, companies having a Zacks Rank #1 have strong chances of performing better than the... Read >>

Ingram Micro, ESET Ink Distribution Deal - Analyst Blog

Technology distribution company, Ingram Micro ( IM ) signed a deal last week with ESET, a provider of digital security solutions, for the distribution of ESET's suite of security products to channel partners in the U.S. ESET offers a... Read >>